Company profile
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Dror Ortho-Design, Inc.
27 Sep 23
4
NRX Pharmaceuticals, Inc.
11 Sep 23
4/A
NRX Pharmaceuticals, Inc.
23 Nov 22
4
NRX Pharmaceuticals, Inc.
21 Nov 22
4
NRX Pharmaceuticals, Inc.
10 Jun 21
3
NRX Pharmaceuticals, Inc.
10 Jun 21
SC 13G/A
Galmed Pharmaceuticals Ltd.
14 Feb 19
SC 13G/A
Galmed Pharmaceuticals Ltd.
26 Jan 18
SC 13G/A
Galmed Pharmaceuticals Ltd.
13 Feb 17
SC 13G
Galmed Pharmaceuticals Ltd.
13 Jan 15
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Aug 23 | Hurvitz Chaim | Common Stock, par value $0.001 per share | Buy | Acquire P | No | No | 0.2875 | 70,000 | 20.13 k | 570,000 |
14 Aug 23 | Hurvitz Chaim | Common Warrants Common Stock | Grant | Acquire A | Yes | No | 0.033 | 42,417,309 | 1.40 mm | 42,417,309 |
14 Aug 23 | Hurvitz Chaim | Series A Convertible Preferred Stock Common Stock | Grant | Acquire A | Yes | No | 0.011 | 592,150.79 | 6.51 k | 592,150.79 |